Role of Renin Secretion and Kidney Function in Hypertension and Attendant Heart Attack and Stroke
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 14 (1-2) , 285-305
- https://doi.org/10.3109/10641969209036189
Abstract
Control of blood pressure usually has not, by itself, affected the incidence of heart attack in hypertensive patients. This suggests a need for cause-specific therapy targeted against mechanisms that engage the risks of myocardial infarction. Study of the renin system, the ongoing, long-term servo-control over blood pressure and electrolyte homeostasis may provide answers. Inappropriately high renin production, generating the powerful vasoconstrictor, angiotensin II, may cause ischemic vascular damage in the heart, kidney and brain, predisposing to infarction. Many clinical situations associated with high plasma renin levels are accompanied by striking vascular damage, heart attack, or stroke. A recent prospective study of 1,717 hypertensive patients shows an unequivocally positive relationship between myocardial infarction and high-renin status regardless of other risk factors such as smoking, hypercholesteremia, or diabetes. The data also suggest the possibility that renin is a continuous variable, since the risk of heart attack was significantly weaker in medium-renin than in high and significantly greater than in low renin subjects. These observations are in keeping with concept that any renin secretion in the face of arterial hypertension is abnormal, since the truly normal kidney completely turns off its renin secretion. Thus the renin-sodium profile appears to be especially useful for evaluating the large fraction of patients who develop heart attacks in the absence of these other risk factors. Altogether, these findings suggest that a renin test should be performed routinely in hypertensive patients, the better to assess prognosis and design appropriate anti-renin therapy.Keywords
This publication has 28 references indexed in Scilit:
- The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatmentProgress in Cardiovascular Diseases, 1978
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- CORONARY HEART-DISEASE AFTER TREATMENT OF HYPERTENSIONThe Lancet, 1978
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977
- Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasinThe American Journal of Medicine, 1976
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974
- Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular diseaseThe American Journal of Medicine, 1972
- Essential Hypertension: Renin and Aldosterone, Heart Attack and StrokeNew England Journal of Medicine, 1972
- LONG-TERM OBSERVATIONS ON HIGH BLOOD-PRESSURE PRESENTING IN FIT YOUNG MENThe Lancet, 1971
- Prolonged Infusions of Angiotensin II and Norepinephrine and Blood Pressure, Electrolyte Balance, and Aldosterone and Cortisol Secretion in Normal Man and in Cirrhosis with Ascites*Journal of Clinical Investigation, 1965